Intellia Therapeutics Inc buy Raymond James
Start price
10.11.23
/
50%
€22.91
Target price
10.11.24
€53.33
Performance (%)
-12.22%
Price
28.08.24
€20.11
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -12.22%. This prediction currently runs until 10.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -5.007% | -5.007% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by Raymond_James for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Raymond James from $78.00 to $57.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat